| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2999 |
| Trial ID | NCT05338931 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AT101 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma |
| Year | 2022 |
| Country | Korea,Republic of |
| Company sponsor | AbClon |
| Other ID(s) | AbClon |
| Cohort 1 | |||||||
|
|||||||